Edwards Lifesciences ROE 2012-2026 | EW
Current and historical return on equity (ROE) values for Edwards Lifesciences (EW) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Edwards Lifesciences ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2026-06-30 | $1.01B | $10.40B | 9.66% |
| 2026-03-31 | $1.10B | $10.37B | 10.57% |
| 2025-12-31 | $1.07B | $10.34B | 10.38% |
| 2025-09-30 | $1.37B | $10.27B | 13.32% |
| 2025-06-30 | $4.15B | $10.12B | 41.00% |
| 2025-03-31 | $4.18B | $9.34B | 44.75% |
| 2024-12-31 | $4.18B | $8.59B | 48.60% |
| 2024-09-30 | $4.16B | $7.76B | 53.63% |
| 2024-06-30 | $1.47B | $7.03B | 20.94% |
| 2024-03-31 | $1.41B | $6.77B | 20.89% |
| 2023-12-31 | $1.40B | $6.49B | 21.62% |
| 2023-09-30 | $1.43B | $6.26B | 22.86% |
| 2023-06-30 | $1.39B | $6.13B | 22.66% |
| 2023-03-31 | $1.49B | $6.01B | 24.78% |
| 2022-12-31 | $1.52B | $5.95B | 25.56% |
| 2022-09-30 | $1.46B | $5.96B | 24.48% |
| 2022-06-30 | $1.46B | $5.79B | 25.12% |
| 2022-03-31 | $1.54B | $5.59B | 27.54% |
| 2021-12-31 | $1.50B | $5.29B | 28.40% |
| 2021-09-30 | $1.48B | $4.98B | 29.70% |
| 2021-06-30 | $1.46B | $4.64B | 31.50% |
| 2021-03-31 | $0.85B | $4.32B | 19.70% |
| 2020-12-31 | $0.82B | $4.13B | 19.95% |
| 2020-09-30 | $0.79B | $4.03B | 19.73% |
| 2020-06-30 | $0.74B | $3.93B | 18.95% |
| 2020-03-31 | $1.11B | $3.84B | 28.85% |
| 2019-12-31 | $1.05B | $3.73B | 28.09% |
| 2019-09-30 | $0.77B | $3.48B | 22.27% |
| 2019-06-30 | $0.73B | $3.36B | 21.56% |
| 2019-03-31 | $0.77B | $3.28B | 23.37% |
| 2018-12-31 | $0.72B | $3.23B | 22.40% |
| 2018-09-30 | $0.71B | $3.18B | 22.41% |
| 2018-06-30 | $0.66B | $3.13B | 20.98% |
| 2018-03-31 | $0.56B | $3.08B | 18.20% |
| 2017-12-31 | $0.58B | $2.95B | 19.76% |
| 2017-09-30 | $0.75B | $2.87B | 25.99% |
| 2017-06-30 | $0.72B | $2.75B | 26.05% |
| 2017-03-31 | $0.66B | $2.63B | 24.97% |
| 2016-12-31 | $0.57B | $2.52B | 22.62% |
| 2016-09-30 | $0.55B | $2.49B | 22.16% |
| 2016-06-30 | $0.53B | $2.42B | 21.83% |
| 2016-03-31 | $0.52B | $2.38B | 21.66% |
| 2015-12-31 | $0.50B | $2.36B | 21.00% |
| 2015-09-30 | $0.46B | $2.28B | 20.32% |
| 2015-06-30 | $0.44B | $2.18B | 20.14% |
| 2015-03-31 | $0.87B | $2.09B | 41.80% |
| 2014-12-31 | $0.81B | $1.87B | 43.31% |
| 2014-09-30 | $0.78B | $1.71B | 45.42% |
| 2014-06-30 | $0.76B | $1.56B | 48.68% |
| 2014-03-31 | $0.31B | $1.48B | 20.67% |
| 2013-12-31 | $0.39B | $1.54B | 25.29% |
| 2013-09-30 | $0.40B | $1.52B | 26.48% |
| 2013-06-30 | $0.40B | $1.55B | 25.54% |
| 2013-03-31 | $0.37B | $1.51B | 24.50% |
| 2012-12-31 | $0.29B | $1.46B | 19.93% |
| 2012-09-30 | $0.27B | $1.43B | 18.60% |
| 2012-06-30 | $0.25B | $1.38B | 17.98% |
| 2012-03-31 | $0.24B | $1.37B | 17.41% |
| 2011-12-31 | $0.24B | $1.36B | 17.44% |
| 2011-09-30 | $0.24B | $1.35B | 17.68% |
| 2011-06-30 | $0.24B | $1.32B | 17.79% |
| 2011-03-31 | $0.24B | $1.26B | 18.73% |
| 2010-12-31 | $0.22B | $1.20B | 18.20% |
| 2010-09-30 | $0.20B | $1.17B | 17.33% |
| 2010-06-30 | $0.23B | $1.13B | 20.19% |
| 2010-03-31 | $0.22B | $1.10B | 19.80% |
| 2009-12-31 | $0.23B | $1.05B | 22.03% |
| 2009-09-30 | $0.22B | $0.98B | 22.58% |
| 2009-06-30 | $0.18B | $0.93B | 19.46% |
| 2009-03-31 | $0.17B | $0.90B | 19.14% |
| 2008-12-31 | $0.13B | $0.86B | 15.05% |
| 2008-09-30 | $0.11B | $0.85B | 12.64% |
| 2008-06-30 | $0.10B | $0.83B | 12.36% |
| 2008-03-31 | $0.10B | $0.81B | 12.08% |
| 2007-12-31 | $0.11B | $0.81B | 13.90% |
| 2007-09-30 | $0.12B | $0.79B | 14.91% |
| 2007-06-30 | $0.12B | $0.77B | 15.24% |
| 2007-03-31 | $0.12B | $0.75B | 15.82% |
| 2006-12-31 | $0.13B | $0.73B | 17.93% |
| 2006-09-30 | $0.15B | $0.72B | 20.81% |
| 2006-06-30 | $0.12B | $0.70B | 16.74% |
| 2006-03-31 | $0.10B | $0.68B | 13.89% |
| 2005-12-31 | $0.08B | $0.67B | 12.03% |
| 2005-09-30 | $0.07B | $0.65B | 10.32% |
| 2005-06-30 | $0.08B | $0.63B | 13.09% |
| 2005-03-31 | $0.10B | $0.62B | 15.44% |
| 2004-12-31 | $0.00B | $0.60B | 0.34% |
| 2004-09-30 | $0.00B | $0.60B | -0.84% |
| 2004-06-30 | $0.01B | $0.59B | 1.35% |
| 2004-03-31 | $0.00B | $0.59B | 0.51% |
| 2003-12-31 | $0.08B | $0.58B | 13.82% |
| 2003-09-30 | $0.08B | $0.56B | 14.95% |
| 2003-06-30 | $0.04B | $0.53B | 7.81% |
| 2003-03-31 | $0.05B | $0.51B | 10.09% |
| 2002-12-31 | $0.06B | $0.49B | 11.61% |
| 2002-09-30 | $0.05B | $0.47B | 11.04% |
| 2002-06-30 | $0.08B | $0.46B | 18.28% |
| 2002-03-31 | $0.00B | $0.44B | -0.68% |
| 2001-12-31 | $-0.01B | $0.44B | -2.51% |
| 2001-09-30 | $-0.01B | $0.43B | -2.77% |
| 2001-06-30 | $-0.02B | $0.44B | -5.28% |
| 2001-03-31 | $-0.28B | $0.44B | -63.48% |
| 2000-12-31 | $-0.27B | $0.49B | -55.57% |
| 2000-09-30 | $-0.24B | $0.69B | -34.72% |
| 2000-06-30 | $-0.24B | $0.58B | -40.72% |
| 2000-03-31 | $0.09B | $0.48B | 18.25% |
| 1999-12-31 | $0.08B | $0.31B | 26.80% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $49.242B | $6.068B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.884B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $133.518B | 45.26 |
| IQVIA Holdings (IQV) | United States | $43.729B | 23.39 |
| Waters (WAT) | United States | $40.283B | 29.97 |
| IDEXX Laboratories (IDXX) | United States | $40.144B | 35.83 |
| Alcon (ALC) | Switzerland | $33.505B | 20.78 |
| DexCom (DXCM) | United States | $31.955B | 33.21 |
| Mettler-Toledo (MTD) | United States | $25.762B | 28.65 |
| STERIS (STE) | Ireland | $20.832B | 20.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.759B | 0.00 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $14.762B | 17.70 |
| Penumbra (PEN) | United States | $12.599B | 83.08 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.279B | 8.59 |
| Globus Medical (GMED) | United States | $10.173B | 15.40 |
| Glaukos (GKOS) | United States | $10.092B | 0.00 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.390B | 27.95 |
| Teleflex (TFX) | United States | $5.521B | 14.89 |
| LivaNova (LIVN) | United Kingdom | $4.442B | 22.46 |
| Integer Holdings (ITGR) | United States | $4.287B | 19.86 |
| Pulse Biosciences (PLSE) | United States | $3.752B | 0.00 |
| Veracyte (VCYT) | United States | $3.313B | 27.11 |
| TransMedics (TMDX) | United States | $2.967B | 43.58 |
| AxoGen (AXGN) | United States | $2.354B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.153B | 27.17 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 17.62 |
| Nihon Kohden (NHNKY) | Japan | $1.694B | 15.52 |
| Alphatec Holdings (ATEC) | United States | $1.677B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.301B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.36 |
| Artivion (AORT) | United States | $1.217B | 46.24 |
| PROCEPT BioRobotics (PRCT) | United States | $1.204B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.170B | 0.00 |
| OPKO Health (OPK) | United States | $1.164B | 0.00 |
| IRadimed (IRMD) | United States | $1.055B | 46.11 |
| Anteris Technologies Global (AVR) | Australia | $0.850B | 0.00 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.753B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.680B | 16.37 |
| AngioDynamics (ANGO) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.583B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.570B | 1644.00 |
| Tactile Systems Technology (TCMD) | United States | $0.511B | 20.90 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.448B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.420B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.411B | 0.00 |
| 908 Devices (MASS) | United States | $0.402B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.371B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.334B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.301B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.266B | 0.00 |
| RxSight (RXST) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.159B | 0.00 |
| FocalTherics (FOCL) | France | $0.154B | 0.00 |
| Inogen (INGN) | United States | $0.139B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Hyperfine (HYPR) | United States | $0.085B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.083B | 0.00 |
| CVRx (CVRX) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 23.27 |
| DarioHealth (DRIO) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.059B | 0.00 |
| Envoy Medical (COCH) | United States | $0.056B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| InspireMD (NSPR) | United States | $0.038B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.036B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Accuray (ARAY) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |